Webinar | February 1, 2022

Research Continuity During COVID-19

Source: Castor

The COVID-19 pandemic is disrupting almost every aspect of life in some way. Clinical trials are no exception, and many researchers are concerned that their studies may be delayed or paused indefinitely as the pandemic progresses.

In this webinar, Derk Arts, MD, PhD, CEO of Castor, and Baljit (Boo) Samra, Strategic Advisor and former COO of Duke Clinical Research Institute, shared:

  1. Insights on how to continue moving your research forward during this pandemic.
  2. Tips on how to ensure research continuity during COVID-19 by running your trial with a more decentralized approach.
access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Castor